Movement Alert|China Taiping Rises 3.59% in Regular Trading, Ex-Dividend Date Approaching with Brokers Bullish on Q2 Earnings Recovery

Market Focus07-06

On July 6, China Taiping rose 3.59% in regular trading, trading at HKD 20.44 per share, with turnover of HKD 94.22 million. The stock continued its upward momentum as the ex-dividend date of July 8 draws near.

On the news front, the company is set to distribute a final dividend of HKD 1.23 per share, representing a year-over-year increase of 251%, attracting capital to position ahead of the record date. The substantial dividend increase reflects the company's strong 2025 performance, with shareholder-attributable net profit surging 220.9% year-over-year to HKD 27.059 billion. Guojin Securities noted in a research report that the insurance sector's Q2 earnings are expected to achieve high growth, with valuation recovery on the horizon, recommending attention to China Taiping among other targets.

Within the Life and Health Insurance sector, peers also advanced broadly, with Sunshine Insurance up 4.99%, China Life up 2.75%, and Ping An up 1.92%, indicating sustained sector-wide recovery momentum.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment